SWX:ROGPharmaceuticals
Roche Stock Slides 9.5% as New Drug Developments Spark Fresh Valuation Debate
Ever find yourself wondering if Roche Holding is a hidden gem or just another pharmaceutical heavyweight trading at a premium? You are not alone. Today we are cutting through the noise to tackle exactly how to think about its value.
Despite a recent 3.0% dip over the last week and a 9.5% slide in the past month, Roche Holding is still up 1.1% since the start of the year. This suggests the market is still weighing its long-term prospects against short-term bumps.
Recent announcements about...